However, given the well-differentiated, less aggressive tumor types that STAT5 is often found in, there is evidence that STAT5 can act as a suppressor of oncogenic activity, at least in part, to reduce tumorigenic potential. The gene discussed is STAT5A; the disease is neoplasm.